Blue Horseshoe Stocks: PZOO Rehash


Pazoo, Inc. PZOO – Updates

Readers who have been following our reports at least since November will remember our talking about this stock, and since that time there have been several developments with Pazoo. For that reason we will be taking another look at PZOO this morning,  reviewing those updates the company has sent over the wires in the past several weeks.

When we first began tracking this play in the fall, the company had just begun to explore opportunities in the cannabis sector, and it has shown dedication to that goal by making significant progress in that area in recent months through its partly-owned partner, as well as a new wholly-owned subsidiary.

Nevada cannabis testing firm MA & Associates, in which PZOO holds a 40% interest, on December 11th announced the first purchase order of product testing from one of the state’s largest licensed growers, tentatively set to begin at the end of this month. >> VIEW PR

A week later, it was revealed that the agency had entered into another agreement to provide exclusive testing on all of their marijuana grown for the next two years. It will begin with 100,000 square feet of ‘grow’ (An estimated contract value of $1M/year) with the intention of expanding up to 875,000 sq.ft. of  in the next two years. >> VIEW PR

In another more recent development related to its expansion into the cannabis sector, PZOO added Harris Lee, LLC as a 100% Wholly-Owned Subsidiary which is also operates in the niche business of medical marijuana testing. >> View PR

*In addition to its growing involvement in the medical marijuana space, Pazoo still operates its health & wellness web portal and store at PAZOO.COM.  Its accompanying podcast, Pazoo Radio, is now up to its 9th episode, and includes a wide range of topics along and special guests >> GO TO PAZOO RADIO

PZOO CHART:

As a quick glance at the chart will show, it appears to be a good time to turn our focus to PZOO again from a technical standpoint as well. Lately, we’ve had quite a bit of good fortune relating to bottom plays rebounding off of their 52-week lows, and that’s precisely the position in which we now find this stock. We’ll initially be looking for PZOO to challenge primary resistance at the 50DMA of .0183.

We also want to highlight this morning’s PR regarding new members of management joining the team to help facilitate PZOO’s aggressively planned expansion into the marijuana testing business:

WHIPPANY, N.J., Feb. 3, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (PZOO) (German WKN#: A1J3DK) is pleased to announce Antonio Del Hierro and David Lieberthal, Esq. have been nominated to its Board of Directors. >> FULL PR

More Information @ PAZOO.COM